Iwona Poziomkowska-Gęsicka

Dr. Iwona Poziomkowska-Gęsicka

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2014 in Allergy
Verified
Journal Article
Closed access
PDF file
MWMargitta Worm
Margitta Worm
AMA. Moneret‐Vautrin
A. Moneret‐Vautrin
KSK. Scherer
K. Scherer
RLR. Lang
R. Lang
MFM. Fernandez‐Rivas
M. Fernandez‐Rivas
LGL. B. Grabenhenrich
L. B. Grabenhenrich

10 January 2018 in Allergy
Verified
Journal Article
Closed access
PDF file
MWMargitta Worm
Margitta Worm
WFWojciech Francuzik
Wojciech Francuzik
JRJ.‐M. Renaudin
J.‐M. Renaudin
MBM. B. Bilo
M. B. Bilo
VCV. Cardona
V. Cardona
SDSabine Dölle-Bierke
Sabine Dölle-Bierke

24 April 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
SAStefanie Aurich
Stefanie Aurich
SDSabine Dölle-Bierke
Sabine Dölle-Bierke
WFWojciech Francuzik
Wojciech Francuzik
MBMaria Beatrice Bilo
Maria Beatrice Bilo
GCGeorge Christoff
George Christoff
MWMargitta Worm
Margitta Worm
Background: Elicitors and symptoms of anaphylaxis are age dependent. However, little is known about typical features of anaphylaxis in patients aged 65 years or more. Methods: The data from the Network for Online Registration of Anaphylaxis (NORA) considering patients aged ≥65 (elderly) in comparison to data from adults (18–64 years) regarding elicitors, symptoms, comorbidities, and treatment measures were analyzed. Results: We identified 1,123 elderly anaphylactic patients. Insect venoms were the most frequent elicitor in this group (p < 0.001), followed by drugs like analgesics and antibiotics. Food allergens elicited less frequently anaphylaxis (p < 0.001). Skin symptoms occurred less frequently in elderly patients (77%, p < 0.001). The clinical symptoms were more severe in the elderly (51% experiencing grade III/IV reactions), in particular when skin symptoms (p < 0.001) were absent. Most strikingly, a loss of consciousness (33%, p < 0.001) and preexisting cardiovascular comorbidity (59%, p < 0.001) were more prevalent in the elderly. Finally, adrenaline was used in 30% of the elderly (vs. 26% in the comparator group, p < 0.001) and hospitalization was more often required (60 vs. 50%, p < 0.001). Discussion and Conclusion: Anaphylaxis in the elderly is often caused by insect venoms and drugs. These patients suffer more often from cardiovascular symptoms, receive more frequently adrenaline and require more often hospitalization. The data indicate that anaphylaxis in the elderly tends to be more frequently life threatening and patients require intensified medical intervention. The data support the need to recognize anaphylaxis in this patient group, which is prone to be at a higher risk for a fatal outcome.

Verified
Journal Article
Open access
PDF file
JKJan Korbecki
Jan Korbecki
ISIwona Szatkowska
Iwona Szatkowska
PKPatrycja Kupnicka
Patrycja Kupnicka
Wojciech ŻwierełłoWojciech Żwierełło
Wojciech Żwierełło
KBKatarzyna Barczak
Katarzyna Barczak
IBIrena Baranowska-Bosiacka
Irena Baranowska-Bosiacka
CXCL1 is a CXC chemokine, CXCR2 ligand and chemotactic factor for neutrophils. In this paper, we present a review of the role of the chemokine CXCL1 in physiology and in selected major non-cancer diseases of the oral cavity and abdominal organs (gingiva, salivary glands, stomach, liver, pancreas, intestines, and kidneys). We focus on the importance of CXCL1 on implantation and placentation as well as on human pluripotent stem cells. We also show the significance of CXCL1 in selected diseases of the abdominal organs, including the gastrointestinal tract and oral cavity (periodontal diseases, periodontitis, Sjögren syndrome, Helicobacter pylori infection, diabetes, liver cirrhosis, alcoholic liver disease (ALD), non-alcoholic fatty liver disease (NAFLD), HBV and HCV infection, liver ischemia and reperfusion injury, inflammatory bowel disease (Crohn’s disease and ulcerative colitis), obesity and overweight, kidney transplantation and ischemic-reperfusion injury, endometriosis and adenomyosis).

IPIwona Poziomkowska-Gęsicka
Iwona Poziomkowska-Gęsicka
MKMichał Kurek
Michał Kurek
Anaphylaxis is most commonly defined as an acute, severe, potentially life-threatening systemic hypersensitivity reaction. Current expert consensus has defined anaphylaxis as a serious reaction that is rapid in onset and can be fatal, and is a severe, potentially life-threatening systemic hypersensitivity reaction that is still rarely diagnosed. For safety reasons, patients should visit an allergologist to identify potential causes of this reaction. There are no data from other health care centres in Poland presenting characteristics of anaphylactic reactions. Clinical manifestations of anaphylaxis should be analysed, because some patients (10–30%) with anaphylaxis can present without cutaneous findings. This lack of skin/mucosa involvement can lead to misdiagnosis or delayed diagnosis of anaphylaxis. Objectives—to gather epidemiological data on anaphylactic reactions, to identify clinical manifestations of anaphylaxis (organ systems involved), to present diagnostic methods useful for the identification of anaphylaxis triggers, and most importantly, to find causes of anaphylaxis. In this retrospective analysis, we used a questionnaire-based survey regarding patients visiting the Clinical Allergology Department, Pomeranian Medical University (PMU) in Szczecin, between 2006 and 2015. The registry comprised patients with grade II (Ring and Messmer classification) or higher anaphylaxis. Patients with grade I anaphylaxis (e.g., urticaria) were not included in the registry. The incidence of anaphylaxis was higher in women. Clinical manifestations included cutaneous and cardiovascular symptoms, but more than 20% of patients did not present with cutaneous symptoms, which may create difficulties for fast and correct diagnosis. Causes of anaphylaxis were identified and confirmed by means of detailed medical interview, skin tests (STs), and measurement of specific immunoglobulin E (sIgE) and tryptase levels. In the analysed group, the most common cause of anaphylaxis (allergic and nonallergic) was Hymenoptera stinging (wasp), drugs (nonsteroidal anti-inflammatory drugs, NSAIDs) and foods (peanuts, tree nuts, celery). The incidence of anaphylaxis is low, but because of its nature and potentially life-threatening consequences it requires a detailed approach. Comprehensive management of patients who have had anaphylaxis can be complex, so partnerships between allergy specialists, emergency medicine and primary care providers are necessary. Monitoring its range is very important to monitor changes in allergy development.

22 June 2012
Verified
Book Chapter
Closed access
PDF file
EDEdyta Dzieciolowska-Baran
Edyta Dzieciolowska-Baran
ITIwona Teul-Swiniarska
Iwona Teul-Swiniarska
AGAleksandra Katarzyna Gawlikowska-Sroka
Aleksandra Katarzyna Gawlikowska-Sroka
IPIwona Poziomkowska-Gęsicka
Iwona Poziomkowska-Gęsicka
ZZZbigniew Zietek
Zbigniew Zietek